Sneezing News and Research

RSS

FDA approves new nonprescription allergy drug Zyrtec-D

The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.

13 Nov 2007

Relief for seasonal allergic rhinitis sufferers

The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.

29 Oct 2007

Coping with urinary incontinence

For older adults, increased urinary frequency is fairly common.

26 Sep 2007

Aloe vera powder nose spray vaccine shows potential for bird flu treatment

Researchers at Texas A&M University are participating in developing a medicine that is worth sneezing about: a treatment for influenza that forms a jelly when sprayed into the nose.

26 Sep 2007

Gates Foundation digs down deep for TB

The fight against the global tuberculosis (TB) epidemic has received a huge boost in the form of a $280 million grant from the Bill & Melinda Gates Foundation.

20 Sep 2007

What a dirty lot many American men are!

An observational study sponsored by the American Society for Microbiology (ASM) and the Soap and Detergent Association (SDA), has found that almost a third of American men leave public restrooms without washing their hands.

18 Sep 2007

When it comes to washing with soap and water, some Americans seem be slipping up

When it comes to washing with soap and water, some Americans seem be slipping up.

18 Sep 2007

New type of male sling procedure to improve the urinary control

Michael Yarborough, a 58-year-old business owner from Waxahachie, Texas, was fortunate. A routine check-up three years ago revealed prostate cancer, but a side effect of his successful surgery was "driving him nuts."

29 Aug 2007

Special nasal cream will bust deadly superbugs

A special cream enriched with bacteria-busting viruses has been developed by scientists in Britain and it could eradicate deadly superbugs such as MRSA from hospitals.

13 Aug 2007

Taiwanese TB globe trotters back home

In another case of globe trotting tuberculosis (TB) air travelers, a couple from Taiwan are now back home.

31 Jul 2007

System to identify air travel passengers responsible for the unintentional release of germs

Researchers developing a system that uses mathematical models and sensors to locate passengers releasing hazardous materials or pathogens inside airline cabins have shown that the technique can track a substance to an area the size of a single seat.

24 May 2007

Surgeries to treat urinary incontinence in women

The University of California, San Diego Medical Center along with nine other clinical research institutions across the United States has completed the largest randomized clinical trial to date comparing two commonly performed surgical procedures to treat urinary stress incontinence.

22 May 2007

Muscle stem cells treat urinary incontinence

Women with stress urinary incontinence (SUI) treated using muscle-derived stem cell injections to strengthen their sphincter muscles experience long-term improvements in their condition, according to a study led by researchers at the University of Pittsburgh School of Medicine and Sunnybrook Health Sciences Centre in Toronto.

22 May 2007

Extremely drug resistant TB a serious problem in India

Extremely drug resistant TB, or XDR-TB, is a serious problem in India, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.

22 May 2007

Sling better than colposuspension for stress urinary incontinence

A large study by a team of urologists and urogynecologists has found that in a comparison of the two traditional surgical operations for stress urinary incontinence (SUI) in women, using an internal sling to support the uretha was more effective than colposuspension.

22 May 2007

Ranbaxy receives tentative FDA approval for Fexofenadine hydrochloride tablets

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market the antihistamine Fexofenadine Hydrochloride Tablets, 30 mg, 60 mg, and 180 mg.

18 May 2007

Health workers to get mumps booster in battle against the spread of the disease

The outbreak of mumps which is currently rife in parts of Canada has prompted Health officials to make 40,000 doses of a mumps booster available to health workers across Nova Scotia.

14 May 2007

Breakthrough on cytomegalovirus transmission

Researchers at the La Jolla Institute for Allergy & Immunology have shown that cytomegalovirus (CMV) in the salivary glands can be reduced , and in some cases eliminated , through the use of antibodies to enhance the disease-fighting power of the immune system.

11 May 2007

Right medications essential for allergy control

Choosing the right medications is essential to gaining control over symptoms as allergy season comes into full bloom, allergy specialists at UT Southwestern Medical Center warn.

10 May 2007